Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00128297 | Pamidronate Administration in Breast Cancer Patients With Bone Metastases | completed | Phase 4 | 152 | Spanish Breast Cancer Research GroupOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT01298193 | Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer. | completed | Phase 4 | 212 | Spanish Breast Cancer Research GroupOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT00128778 | Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients | completed | Phase 4 | 288 | Spanish Breast Cancer Research GroupOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT04248179 | The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. | completed | Phase 4 | 36 | Zealand University HospitalOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT01975064 | Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane Anesthesia(CAN) | completed | Phase 4 | 5,774 | Uppsala UniversityOTHER | 3 | Dec 14, 2022 | clinicaltrials |
| NCT01035099 | RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF | completed | Phase 4 | 41 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT02549677 | Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer(ELEGANT) | completed | Phase 4 | 294 | Ruijin HospitalOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT02419742 | Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen | completed | Phase 4 | 110 | Hoffmann-La RocheINDUSTRY | 1 | Oct 12, 2022 | clinicaltrials |
| NCT03948568 | Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)(REaCT-RETT) | completed | Phase 4 | 262 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT02679755 | Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer | completed | Phase 4 | 252 | PfizerINDUSTRY | 2 | Jul 27, 2022 | clinicaltrials |
| NCT05420454 | A Study for the Neoadjuvant Treatment of Breast Cancer | recruiting | Phase 4 | 1,576 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 1, 2022 | clinicaltrials |
| NCT05420467 | A Study for the Adjuvant Treatment of Breast Cancer | recruiting | Phase 4 | 2,413 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 1, 2022 | clinicaltrials |
| NCT04074460 | Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study(VAPOR-C) | completed | Phase 4 | 169 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Jun 9, 2022 | clinicaltrials |
| NCT05302336 | AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer | unknown | Phase 4 | 402 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT05291910 | Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer | unknown | Phase 4 | 70 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 23, 2022 | clinicaltrials |
| NCT04705883 | Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors(VIBRA) | completed | Phase 4 | 10 | Hospital Clinic of BarcelonaOTHER | 1 | Feb 22, 2022 | clinicaltrials |
| NCT05191914 | Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors | unknown | Phase 4 | 20 | Liaoning Cancer Hospital & InstituteOTHER | 0 | Jan 14, 2022 | clinicaltrials |
| NCT03220178 | Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy(PRECYCLE) | terminated | Phase 4 | 532 | Palleos Healthcare GmbHINDUSTRY | 1 | Jan 6, 2022 | clinicaltrials |
| NCT04929548 | Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP | not yet recruiting | Phase 4 | 20 | Wuhan UniversityOTHER | 0 | Jan 5, 2022 | clinicaltrials |
| NCT05131841 | Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC | unknown | Phase 4 | 60 | Zhejiang Cancer HospitalOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT04726878 | ESP in Breast Surgery Due to Cancer | completed | Phase 4 | 75 | Medical University of LublinOTHER | 1 | Nov 9, 2021 | clinicaltrials |
| NCT01176916 | Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China | completed | Phase 4 | 564 | PfizerINDUSTRY | 1 | Oct 27, 2021 | clinicaltrials |
| NCT02479347 | Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine | completed | Phase 4 | 2,158 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT04031885 | A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer | terminated | Phase 4 | 4 | Eli Lilly and CompanyINDUSTRY | 2 | Aug 24, 2021 | clinicaltrials |
| NCT04136782 | Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer | recruiting | Phase 4 | 110 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT04137640 | Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy | unknown | Phase 4 | 152 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT03511378 | Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer | completed | Phase 4 | 138 | Lupin Ltd.INDUSTRY | 1 | Jun 15, 2021 | clinicaltrials |
| NCT00688909 | Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer(REAL) | completed | Phase 4 | 261 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT04487912 | Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer | withdrawn | Phase 4 | 0 | University Hospital, GhentOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT03038152 | Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery | completed | Phase 4 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT02864030 | PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment | completed | Phase 4 | 200 | Oncologia Medica dell'Ospedale FatebenefratelliOTHER_GOV | 1 | Mar 4, 2021 | clinicaltrials |
| NCT04029467 | Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery | unknown | Phase 4 | 44 | Lebanese American UniversityOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT03738527 | SEroma Reduction pOst MAstectomy "SEROMA Study"(SEROMA) | unknown | Phase 4 | 100 | Hamilton Health Sciences CorporationOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT02721433 | 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases(REaCT-BTA) | completed | Phase 4 | 263 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT04009941 | Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer | completed | Phase 4 | 104 | Peking UniversityOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT02822196 | Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies | withdrawn | Phase 4 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT03397914 | Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections | completed | Phase 4 | 70 | National Cancer Institute, EgyptOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT02502864 | Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide | completed | Phase 4 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT02287675 | Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer(Lymphoseek) | completed | Phase 4 | 40 | Kettering Health NetworkOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT04434404 | Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy | completed | Phase 4 | 83 | Horus UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT02816112 | Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia(REaCT-TC2) | completed | Phase 4 | 458 | Ottawa Hospital Research InstituteOTHER | 1 | May 27, 2020 | clinicaltrials |
| NCT02627560 | The Effect of Topical Tranexamic Acid on Bleeding and Seroma Formation in After Undergoing Mastectomy | completed | Phase 4 | 202 | St. Olavs HospitalOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT02005770 | Anesthesia and Circulating Tumor Cells in Breast Cancer | completed | Phase 4 | 221 | University of ZurichOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT04261179 | Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer(SENTINELSEEK) | unknown | Phase 4 | 30 | Anna CrucetaOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT04218149 | Serratus Plane Block vs Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Unilateral Breast Surgery | completed | Phase 4 | 70 | Sisli Hamidiye Etfal Training and Research HospitalOTHER | 1 | Jan 31, 2020 | clinicaltrials |
| NCT03348696 | Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients(REaCT-TAPS) | completed | Phase 4 | 124 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 9, 2020 | clinicaltrials |
| NCT03305757 | Seroma Reduction After Mastectomy(SAM) | completed | Phase 4 | 339 | Zuyderland Medisch CentrumOTHER | 1 | Dec 3, 2019 | clinicaltrials |
| NCT03125941 | High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy(DEX-MAS) | completed | Phase 4 | 130 | Rigshospitalet, DenmarkOTHER | 1 | Dec 2, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Mar 28, 2023source: clinicaltrials